Demographics of lung cancer in women at Mansoura University
Official title: Demographics of Lung Cancer in Female Patients: A Retrospective Based Analysis
Run by Mansoura University Hospital · NCT07122245 · Data updated 2026-11-12
This project looks at demographic, smoking and exposure information from women diagnosed with primary bronchogenic lung cancer at Mansoura University over the past 10 years to see which factors are linked to their disease.
Quick facts
| Study type | Observational |
|---|---|
| Sex | Women only |
| Enrollment | 300 (estimated) |
| Sponsor | Mansoura University Hospital Academic / other |
| Locations | 1 site (Al Mansurah) |
| Status | Recruiting |
| Started | August 7, 2025 |
| Main results expected | December 7, 2026 |
| Study ends | April 7, 2027 |
| Registry record updated | August 18, 2026 |
| Trial ID | NCT07122245 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Female patients with documented primary bronchogenic carcinoma diagnosed and treated at the Chest Diseases Department/Oncology Center, Mansoura University within the past ten years are the intended participants.
✕Probably not a fit
Women with lung metastases from other primary cancers, patients without records at Mansoura University, or those diagnosed outside the 10-year window are not included and are unlikely to benefit from this dataset.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a retrospective observational review of female patients diagnosed with primary bronchogenic carcinoma at the Chest Diseases Department, Oncology Center, Mansoura University during the last ten years. Investigators will extract demographic variables, smoking history, secondhand smoke exposure, occupational and environmental risk factors, and clinical presentation from hospital records. Patients with lung metastases from other primary cancers are excluded. The team will use descriptive statistics and subgroup comparisons to summarize patterns and identify associations within this local cohort.
Why it matters
Potential benefit: If successful, the project could clarify common risk patterns among women in this population and support targeted prevention or earlier detection efforts.
How similar studies have gone: Other regional and international demographic studies have identified distinct risk patterns in women—including sizable proportions of never-smokers—so this work builds on prior observational findings rather than testing a new therapy.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All female patients presented with bronchogenic carcinoma patients and diagnosed at chest diseases department, Oncology Center Mansoura University (OCMU) in last 10 years. Exclusion Criteria: * lung metastasis ( not primary bronchogenic carcinoma)
Where it's running
-
Mohamed AbdElmoniem
Al Mansurah, Egypt Recruiting
Study contacts
- Principal investigator: Mohamed AbdElmoniem — Lecturer of chest medicine faculty of medicine Mansoura university
- Study coordinator: Mohamed AbdElmoniem
- Email: dr.m1993@mans.edu.eg
- Phone: 01014008473
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
-
ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients
This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.
-
Olive oil before lung cancer surgery to see if it lowers chylothorax
This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.